Helixera

Why these diseases

Ten disease landscapes where clarity cannot wait.

Helixera exists to ensure no one misses a meaningful advancement in the disease that matters to them. We chose our first ten diseases deliberately: each combines profound human need with a research landscape that is active, fragmented, and difficult to follow continuously.

10

approved diseases

3

connected focus areas

0

medical advice

1

continuous intelligence mission

A patient, caregiver, and neurologist reviewing information together in a modern clinic

Neuro-Degenerative

High-impact disease landscapes where families are balancing urgent questions with rapidly expanding research.

Neuro-Degenerative

ALS

ALS moves quickly. The intelligence surrounding it should move with equal purpose.

Neuro-Degenerative

Alzheimer's

A vast research field should not leave families searching alone.

Neuro-Degenerative

Parkinson's

Progress spans movement, biology, devices, care, and a growing range of therapeutic ideas.

A family and rare-disease care team meeting in a welcoming pediatric research center

Orphan/Rare

Closely connected communities where every credible trial, designation, and scientific step can matter.

Orphan/Rare

Huntington's

A closely connected community deserves a continuous view of every credible step forward.

Orphan/Rare

SMA

Rapid therapeutic change makes long-term, source-linked continuity essential.

Orphan/Rare

Cystic Fibrosis

Transformative progress still arrives unevenly, one genotype and program at a time.

An oncology patient and physician reviewing precision imaging in a modern cancer center

Precision Oncology

Fast-moving cancer research where trial setting, biomarkers, timing, and evidence quality shape the meaning of progress.

Precision Oncology

Glioblastoma

In an unforgiving disease, experimental signals need context, precision, and restraint.

Precision Oncology

Pancreatic Cancer

Small advances can carry outsized meaning in a landscape that demands speed and rigor.

Precision Oncology

Melanoma

Fast-moving treatment science demands an equally connected view of evidence and access.

Precision Oncology

Small Cell Lung Cancer

Aggressive disease biology makes timely, source-grounded monitoring especially important.

Helixera disease pages organize source-linked intelligence and do not provide diagnosis, treatment recommendations, medical advice, or emergency guidance.

Explore Helixera